Account dashboard

Document	Last change		Status	Email	Client code	Assignee	Title	Last checked
20070066660	2008-12-10	•green	Patented Case	demo	867-5309	Merck Patent GmbH	Benzimidazolyl derivatives	2 years, 9 mo ago
20070014934	2009-05-01	•yellow	Non Final Action Mailed	demo	867-5309	MERCK PATENT GMBH	Substituted anthracenes	2 years, 9 mo ago
20060270673	2008-09-22	•green	Patented Case	demo	867-5309	MERCK & CO., INC.	Inhibitors of akt activity	2 years, 9 mo ago
20070179114	2009-02-05	•red	Final Rejection Mailed	demo	867-5309	Metabasis Therapeutics, Inc.	Novel 2'-C methyl nucleoside derivatives	2 years, 10 mo ago
20060252936	2008-12-16	•green	Patented Case	demo	867-5309	Merck Patent GmbH	Method for the production of highly pure tris-ortho-metalated organo-iridium compounds	2 years, 9 mo ago
20070213374	2008-11-19	•blue	Docketed New Case - Ready for Examination	demo	867-5309	Merck Patent GmbH	Malonamide Derivatives	2 years, 8 mo ago
20070060618	2009-05-05	•gray	Abandoned -- Failure to Pay Issue Fee	demo	867-5309	MERCK & CO., INC.	Alkyne derivatives as tracers for metabotropic glutamate receptor binding	2 years, 9 mo ago
20070225347	2008-11-17	•blue	Docketed New Case - Ready for Examination	demo	867-5309	Merck Patent GmbH	Imidazole Derivatives	2 years, 9 mo ago
20070161677	2008-11-18	•blue	Docketed New Case - Ready for Examination	demo	867-5309	Merck Patent GmbH	Bisarylurea derivatives	2 years, 9 mo ago
20070123690	2009-05-21	•blue	Response to Non-Final Office Action Entered and Forwarded to Examiner	demo	867-5309	Merck Patent GmbH	Conjugated polymers, representation thereof, and use of the same	2 years, 9 mo ago
20070043015	2008-12-03	•green	Patented Case	demo	867-5309	MERCK & CO., INC.	Phenyl pyrrolidine ether tachykinin receptor antagonists	2 years, 10 mo ago
20070221914	2009-04-08	•yellow	Non Final Action Mailed	demo	867-5309	Merck Patent GmbH Patents & Scientific Information	Electronic Devices Comprising Organic Semiconductors	2 years, 9 mo ago
20070036824	2009-02-11	•green	Patented Case	demo	867-5309	MERCK & CO., INC.	Optimized expression of hpv 58 l1 in yeast	2 years, 9 mo ago
20070093532	2009-05-07	•yellow	Non Final Action Mailed	demo	867-5309	MERCK PATENT GmbH	Benzimidazole carboxamides as raf kinase inhibitors	2 years, 9 mo ago
20070022901	2008-09-02	•gray	Abandoned -- Failure to Respond to an Office Action	demo	867-5309	XSYS Print Solutions Deutschland GmbH	Metallic ink, and use thereof for improving prints	2 years, 9 mo ago
20070004714	2009-03-12	•yellow	Notice of Allowance Mailed -- Application Received in Office of Publications	demo	867-5309	MERCK & CO., INC.	Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity	2 years, 9 mo ago
20070105115	2009-03-10	•blue	Response to Non-Final Office Action Entered and Forwarded to Examiner	demo	867-5309	MERCK SANTE	Promoter of the human fatp5 gene and uses	2 years, 9 mo ago
20070170395	2009-04-30	•blue	Publications -- Issue Fee Payment Verified	demo	867-5309	MERCK PATENT GESELLSCHAFT	Liquid crystal medium	2 years, 9 mo ago
20070178098	2009-04-24	•yellow	Non Final Action Mailed	demo	867-5309	Merck Patent GmbH	Interleukin-6 antagonists	2 years, 9 mo ago
20060228332	2009-03-09	•blue	Publications -- Issue Fee Payment Verified	demo	867-5309	MERCK Patent GmbH	Assembly and folding of Fc-interferon-beta fusion proteins	2 years, 9 mo ago
20070093472	2009-03-06	•yellow	Notice of Allowance Mailed -- Application Received in Office of Publications	demo	867-5309	MERCK PATENT GMBH	1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors xa and viia for the treatment of thromboses	2 years, 9 mo ago
20070054933	2008-10-15	•green	Patented Case	demo	867-5309	Merck & Co., Inc	17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators	2 years, 9 mo ago
20070164273	2009-03-17	•blue	Response to Non-Final Office Action Entered and Forwarded to Examiner	demo	867-5309	Merck Patent GmbH	Organic electronic devices	2 years, 9 mo ago

Status colors

Color	Meaning	Example statuses
•red	Final rejection	Final rejection
•yellow	Non-final rejection / Awaiting issue	Non-final rejection; Awaiting issue
•blue	Correspondence received	Docketed New Case - Ready for Examination; TSS review complete; Application Undergoing Preexam Processing; Application Dispatched from Preexam, Not Yet Docketed
•gray	Inactive case	Abandoned -- Failure to Respond to an Office Action; Abandoned -- Failure to Pay Issue Fee; Expressly Abandoned -- During Publication Process; Provisional Application Expired
•green	Allowed	Patented Case

Description

Welcome to the account status dashboard page that allows you to see which documents have been checked for updates and when. If you just recently placed an order, your new patent applications may not yet appear in this report -- they will appear after they have been checked at least once for final wrapper updates. You can sort the data by any field (e.g., title or Client code). As always, please do not hesitate to e–mail your account representative at joel@stonelionventures.com.